Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
May 04, 2026
Amphenol (APH): Record Q1 2026 Sales +58% Amid IT Datacom Strength

Amphenol (APH): Record Q1 2026 Sales +58% Amid IT Datacom Strength

Key Takeaways

  • Amphenol reported record Q1 2026 sales of $7.6 billion, up 58% year-over-year and 33% organically, driven by IT datacom demand.
  • Adjusted diluted EPS of $1.06 beat estimates by 12%, with book-to-bill ratio of 1.24:1 signaling strong order backlog.
  • Recent CommScope CCS acquisition bolsters fiber optic capabilities, contributing to segment growth.
  • Analysts maintain overweight ratings with average price targets around $180, reflecting AI-driven optimism.
  • Tickeron's Trending AI Robots feature bots trading APH with annualized returns up to 56% in space components strategies.

APH's Current Market Position

In recent trading, APH shares have faced some volatility after strong quarterly results, amid broader market shifts and profit-taking. The stock pulled back from highs near $154 during sector rotation but stays well above its 52-week low, backed by solid fundamentals in high-growth interconnect areas. Volumes jumped post-earnings, highlighting investor focus on Amphenol's ties to AI datacom and industrial uses. With a market cap over $170 billion, it sits comfortably in its yearly range as end-markets continue to expand.

Key Catalysts Driving Recent Price Action

From what I see, APH's stock jumped in late April after Q1 2026 results on April 29, rising as much as 9% intraday before some pullback from market pressures. Sales hit a record $7.6 billion, up 58% year-over-year (33% organic), fueled by IT datacom demand. That segment grew 47% organically in Communications Solutions ($4.5 billion sales, 30.6% operating margin). Adjusted diluted EPS reached $1.06, beating consensus by $0.11, while GAAP EPS increased 24% to $0.72. Orders came in at $9.4 billion, for a 1.24:1 book-to-bill ratio that points to ongoing strength.

The January 2026 $10.5 billion CommScope CCS acquisition added fiber optic expertise and $0.15 expected EPS accretion for 2026, driving 88% growth in Communications Solutions with clear Q1 impact. Harsh Environment Solutions grew 34% (23% organic) on aerospace and defense trends, and Interconnect and Sensor Systems rose 23% (17% organic).

I also checked APH's patterns using Tickeron's AI Pattern Search Engine, which aligns with the innovations shown at OFC 2026 in early April for high-bandwidth optics in AI data centers. A sustainability report on April 22 reinforced ESG efforts. Analysts stayed positive post-earnings: Seaport lifted its target to $215 from $210, JP Morgan kept overweight, and averages hover near $180 on AI exposure. Shares rose 3.2% on April 30 but dipped toward $142 by early May amid acquisition leverage and China risks. Overall, execution ties to positive sentiment, balanced by macro factors.

Outlook for 2026 and Factors to Watch

One thing that stands out is Amphenol's IT datacom growth potential in AI infrastructure, where fiber optics and high-speed interconnects are essential. Q2 guidance calls for $8.1-$8.2 billion sales (43-45% YoY growth) and adjusted EPS of $1.14-$1.16, showing momentum. Integrating CommScope CCS smoothly will boost telecom scale while handling debt. Diversification into mobile networks, automotive electrification, aerospace, and defense supports this, driven by organic advances.

Risks remain, including supply chain issues, currency swings, China geopolitics, and competition in commoditized areas. M&A can fuel growth, but high valuations need careful execution. Regulatory changes in sustainability and tech standards may shape the long term. I'll be watching book-to-bill and segment margins for cycle resilience.

Tools I'm Using: Tickeron's Trending AI Robots

In my analysis of stocks like APH, I turn to Tickeron's Trending AI Robots page, which highlights the top 25 from 351 AI trading bots across stocks, ETFs, and crypto. These are selected by AI for current market fit, covering strategies like technical analysis, swing trading, trend following, and take-profit/stop-loss setups (e.g., 3% TP/2% SL). Returns range from +23% to +163% annualized, win rates 51%-88%, profit factors to 11.70, across timeframes from 5-minute scalps to multi-day holds. One bot focused on space components—including APH—shows +56% annualized returns and 58% win rate. It's a practical way I gauge trading edges in volatile conditions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: APH

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


Aroon Indicator for APH shows an upward move is likely

APH's Aroon Indicator triggered a bullish signal on September 29, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 324 similar instances where the Aroon Indicator showed a similar pattern. In 246 of the 324 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on APH as a result. In 53 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.

The Moving Average Convergence Divergence (MACD) for APH just turned positive on September 22, 2026. Looking at past instances where APH's MACD turned positive, the stock continued to rise in 35 of 50 cases over the following month. The odds of a continued upward trend are 70%.

APH moved above its 50-day moving average on September 21, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for APH crossed bullishly above the 50-day moving average on September 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.

Following a +1.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where APH advanced for three days, in 250 of 355 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

APH broke above its upper Bollinger Band on September 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 10 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 65, placing this stock better than average.

The Tickeron SMR rating for this company is 27 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. APH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: APH's P/B Ratio (13.477) is slightly higher than the industry average of (5.615). P/E Ratio (42.310) is within average values for comparable stocks, (81.453). Projected Growth (PEG Ratio) (0.968) is also within normal values, averaging (1.658). Dividend Yield (0.006) settles around the average of (0.005) among similar stocks. P/S Ratio (6.859) is also within normal values, averaging (4.796).

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are Corning (NYSE:GLW), Universal Display Corp (NASDAQ:OLED).

Industry description

The Electronic Components industry produces electronic equipment for industries and consumer electronics products, such as mobile devices, televisions, and circuit boards. TE Connectivity Ltd, for example, is a company that designs and manufactures connectivity and sensor products for harsh environments in various industries, such as automotive, industrial equipment, aerospace, and oil & gas. Another major player, Corning Inc., makes advanced optics including end-to-end fiber and wireless solutions for communications networks along with various other technologies catering to industrial and scientific applications.

Market Cap

The average market capitalization across the Electronic Components Industry is 14.08B. The market cap for tickers in the group ranges from 5.86K to 208.67B. APH holds the highest valuation in this group at 208.67B. The lowest valued company is NXOPF at 5.86K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Components Industry was 3%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 18%. OPTX experienced the highest price growth at 38%, while MTEK experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Electronic Components Industry was -23%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was -43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 48
Price Growth Rating: 48
SMR Rating: 72
Profit Risk Rating: 65
Seasonality Score: 27 (-100 ... +100)
View a ticker or compare two or three
APH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of electrical, electronic & fiber optic connectors, coaxial and flat-ribbon cable and interconnect systems

Industry ElectronicComponents

Industry
Electronic Components
Address
358 Hall Avenue
Phone
+1 203 265-8900
Employees
170000
Web
https://www.amphenol.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.